{"id":"e3e6741f-8457-4043-8a49-2ea9f765c695","kind":"companies","code":"UB-C2791","name":"Beacon Biosignals","nameBasis":"source-english","summary":"Beacon Biosignals is a company headquartered in Boston, United States, founded in 2019.","description":"","country":"United States","category":null,"originalName":"Beacon Biosignals","eventDate":null,"website":"https://beacon.bio/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-15T17:11:38.016Z","reviewedAt":"2026-10-15T17:11:38.016Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"b1614c9fa113327dfb3a6d61f1e842fc1128083c88535eb0ca67e7075f7649d3","companyId":null,"foundedYear":2019,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","kind":"news","code":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","name":"Beacon Biosignals raises USD 86 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Beacon Biosignals完成8600万美元B轮融资","eventDate":"2025-11-14T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:51:48.824Z","englishUpdatedAt":"2026-10-15T17:19:59.451Z","reviewedAt":"2026-10-15T17:19:59.451Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1c9a8d7af2a0fd0178f098d60b67fb65728cdcb93f7a0735655a35de7b306f7a","companyId":"e3e6741f-8457-4043-8a49-2ea9f765c695","foundedYear":null,"logoUrl":null,"path":"/news/46b90fd5-9421-4d15-a20e-022fe7b89fc4"},{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":null,"category":null,"originalName":"General Catalyst","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.611Z","englishUpdatedAt":"2026-10-15T21:31:30.008Z","reviewedAt":"2026-10-15T21:31:30.008Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1b9706817cd259631fefca6d7108794233d5b9fd8d61c1a2e0f01a995645ec2d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"f8c88419-8f6c-4a71-85d4-e2adf1902d93","kind":"institutions","code":"UB-I126","name":"Google Ventures","nameBasis":"original-brand","summary":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","description":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","country":null,"category":null,"originalName":"Google Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.604Z","englishUpdatedAt":"2026-10-15T21:41:18.695Z","reviewedAt":"2026-10-15T21:41:18.695Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d04bb12f5ac7eb0ced51f43024c0a2c575f0d09b884de34c37a2a8c878fbb39e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/google-ventures"},{"id":"d25ffb29-81fd-4b4c-9649-632bc2b3e0cc","kind":"people","code":"UB-P916","name":"Jacob Donoghue","nameBasis":"original-brand","summary":"Co-founder and CEO of Beacon Biosignals, leading an AI company developing digital biomarkers for neurological disorders.","description":"Co-founder and CEO of Beacon Biosignals, leading an AI company developing digital biomarkers for neurological disorders.","country":null,"category":null,"originalName":"Jacob Donoghue","eventDate":null,"website":"https://www.linkedin.com/in/jacob-donoghue-mdphd/","sourceUpdatedAt":"2026-10-09T07:08:43.230Z","englishUpdatedAt":"2026-10-15T20:40:16.777Z","reviewedAt":"2026-10-15T20:40:16.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"46a9a048ea8fd9102807b11e4ae5227b8cafb82c5b75fe2694a60488bb0c9488","companyId":"e3e6741f-8457-4043-8a49-2ea9f765c695","foundedYear":null,"logoUrl":null,"path":"/people/jacob-donoghue"},{"id":"b7ec6fab-4be0-41b6-96c9-9ceb75fd50b7","kind":"institutions","code":"UB-I2076","name":"Logos Capital","nameBasis":"original-brand","summary":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","description":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","country":null,"category":null,"originalName":"Logos Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.060Z","englishUpdatedAt":"2026-10-15T20:40:58.196Z","reviewedAt":"2026-10-15T20:40:58.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a0ed63ab290a2e3701938597d81337fc2cc3ae0dc591169e160b435a279ba6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/logos-capital"},{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":null,"category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.617Z","englishUpdatedAt":"2026-10-15T21:44:15.515Z","reviewedAt":"2026-10-15T21:44:15.515Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dd32345516d11666ed6d26c7709c5384c09df6df2a3abb241dd8ddbe317f77e8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/takeda-pharmaceutical-co"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":86000000,"text":"8600万美元","date":"2025-11-14T00:00:00.000Z","round":"Series B","estimate":"$86M"},"years":[2025],"points":[{"year":2025,"date":"2025-11-14T00:00:00.000Z","round":"Series B","value":86000000,"eventIds":["46b90fd5-9421-4d15-a20e-022fe7b89fc4"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","date":"2025-11-14T00:00:00.000Z","round":"Series B","amountText":"8600万美元","estimateUsd":86000000,"estimateLabel":"$86M","estimateNote":null,"investors":"General Catalyst Partners,Logos Capital,Takeda Pharmaceutical Co,GV","institutions":[{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":null,"category":null,"originalName":"General Catalyst","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.611Z","englishUpdatedAt":"2026-10-15T21:31:30.008Z","reviewedAt":"2026-10-15T21:31:30.008Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1b9706817cd259631fefca6d7108794233d5b9fd8d61c1a2e0f01a995645ec2d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"f8c88419-8f6c-4a71-85d4-e2adf1902d93","kind":"institutions","code":"UB-I126","name":"Google Ventures","nameBasis":"original-brand","summary":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","description":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","country":null,"category":null,"originalName":"Google Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.604Z","englishUpdatedAt":"2026-10-15T21:41:18.695Z","reviewedAt":"2026-10-15T21:41:18.695Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d04bb12f5ac7eb0ced51f43024c0a2c575f0d09b884de34c37a2a8c878fbb39e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/google-ventures"},{"id":"b7ec6fab-4be0-41b6-96c9-9ceb75fd50b7","kind":"institutions","code":"UB-I2076","name":"Logos Capital","nameBasis":"original-brand","summary":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","description":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","country":null,"category":null,"originalName":"Logos Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.060Z","englishUpdatedAt":"2026-10-15T20:40:58.196Z","reviewedAt":"2026-10-15T20:40:58.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a0ed63ab290a2e3701938597d81337fc2cc3ae0dc591169e160b435a279ba6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/logos-capital"},{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":null,"category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.617Z","englishUpdatedAt":"2026-10-15T21:44:15.515Z","reviewedAt":"2026-10-15T21:44:15.515Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dd32345516d11666ed6d26c7709c5384c09df6df2a3abb241dd8ddbe317f77e8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/takeda-pharmaceutical-co"}],"newsUrl":null,"evidence":{"headline":"Beacon Biosignals raises USD 86 million in Series B financing","brief":null,"basis":null,"newsPath":"/news/46b90fd5-9421-4d15-a20e-022fe7b89fc4","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","date":"2025-11-14T00:00:00.000Z","round":"Series B","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"General Catalyst Partners,Logos Capital,Takeda Pharmaceutical Co,GV","institutions":[{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":null,"category":null,"originalName":"General Catalyst","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.611Z","englishUpdatedAt":"2026-10-15T21:31:30.008Z","reviewedAt":"2026-10-15T21:31:30.008Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1b9706817cd259631fefca6d7108794233d5b9fd8d61c1a2e0f01a995645ec2d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"f8c88419-8f6c-4a71-85d4-e2adf1902d93","kind":"institutions","code":"UB-I126","name":"Google Ventures","nameBasis":"original-brand","summary":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","description":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","country":null,"category":null,"originalName":"Google Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.604Z","englishUpdatedAt":"2026-10-15T21:41:18.695Z","reviewedAt":"2026-10-15T21:41:18.695Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d04bb12f5ac7eb0ced51f43024c0a2c575f0d09b884de34c37a2a8c878fbb39e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/google-ventures"},{"id":"b7ec6fab-4be0-41b6-96c9-9ceb75fd50b7","kind":"institutions","code":"UB-I2076","name":"Logos Capital","nameBasis":"original-brand","summary":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","description":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","country":null,"category":null,"originalName":"Logos Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.060Z","englishUpdatedAt":"2026-10-15T20:40:58.196Z","reviewedAt":"2026-10-15T20:40:58.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a0ed63ab290a2e3701938597d81337fc2cc3ae0dc591169e160b435a279ba6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/logos-capital"},{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":null,"category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.617Z","englishUpdatedAt":"2026-10-15T21:44:15.515Z","reviewedAt":"2026-10-15T21:44:15.515Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dd32345516d11666ed6d26c7709c5384c09df6df2a3abb241dd8ddbe317f77e8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/takeda-pharmaceutical-co"}],"newsUrl":null,"evidence":{"headline":"Beacon Biosignals raises USD 86 million in Series B financing","brief":null,"basis":null,"newsPath":"/news/46b90fd5-9421-4d15-a20e-022fe7b89fc4","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","kind":"funding","eventDate":"2025-11-14T00:00:00.000Z","revenueDate":null,"round":"B轮","amountText":"8600万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":86000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"General Catalyst Partners,Logos Capital,Takeda Pharmaceutical Co,GV","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":null,"category":null,"originalName":"General Catalyst","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.611Z","englishUpdatedAt":"2026-10-15T21:31:30.008Z","reviewedAt":"2026-10-15T21:31:30.008Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1b9706817cd259631fefca6d7108794233d5b9fd8d61c1a2e0f01a995645ec2d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"f8c88419-8f6c-4a71-85d4-e2adf1902d93","kind":"institutions","code":"UB-I126","name":"Google Ventures","nameBasis":"original-brand","summary":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","description":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","country":null,"category":null,"originalName":"Google Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.604Z","englishUpdatedAt":"2026-10-15T21:41:18.695Z","reviewedAt":"2026-10-15T21:41:18.695Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d04bb12f5ac7eb0ced51f43024c0a2c575f0d09b884de34c37a2a8c878fbb39e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/google-ventures"},{"id":"b7ec6fab-4be0-41b6-96c9-9ceb75fd50b7","kind":"institutions","code":"UB-I2076","name":"Logos Capital","nameBasis":"original-brand","summary":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","description":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","country":null,"category":null,"originalName":"Logos Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.060Z","englishUpdatedAt":"2026-10-15T20:40:58.196Z","reviewedAt":"2026-10-15T20:40:58.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a0ed63ab290a2e3701938597d81337fc2cc3ae0dc591169e160b435a279ba6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/logos-capital"},{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":null,"category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.617Z","englishUpdatedAt":"2026-10-15T21:44:15.515Z","reviewedAt":"2026-10-15T21:44:15.515Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dd32345516d11666ed6d26c7709c5384c09df6df2a3abb241dd8ddbe317f77e8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/takeda-pharmaceutical-co"}],"roundName":"Series B","amountLabel":"$86M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"d25ffb29-81fd-4b4c-9649-632bc2b3e0cc","kind":"people","code":"UB-P916","name":"Jacob Donoghue","nameBasis":"original-brand","summary":"Co-founder and CEO of Beacon Biosignals, leading an AI company developing digital biomarkers for neurological disorders.","description":"Co-founder and CEO of Beacon Biosignals, leading an AI company developing digital biomarkers for neurological disorders.","country":null,"category":null,"originalName":"Jacob Donoghue","eventDate":null,"website":"https://www.linkedin.com/in/jacob-donoghue-mdphd/","sourceUpdatedAt":"2026-10-09T07:08:43.230Z","englishUpdatedAt":"2026-10-15T20:40:16.777Z","reviewedAt":"2026-10-15T20:40:16.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"46a9a048ea8fd9102807b11e4ae5227b8cafb82c5b75fe2694a60488bb0c9488","companyId":"e3e6741f-8457-4043-8a49-2ea9f765c695","foundedYear":null,"logoUrl":null,"path":"/people/jacob-donoghue"}],"productsRelated":[],"investors":[{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":null,"category":null,"originalName":"General Catalyst","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.611Z","englishUpdatedAt":"2026-10-15T21:31:30.008Z","reviewedAt":"2026-10-15T21:31:30.008Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1b9706817cd259631fefca6d7108794233d5b9fd8d61c1a2e0f01a995645ec2d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"f8c88419-8f6c-4a71-85d4-e2adf1902d93","kind":"institutions","code":"UB-I126","name":"Google Ventures","nameBasis":"original-brand","summary":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","description":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","country":null,"category":null,"originalName":"Google Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.604Z","englishUpdatedAt":"2026-10-15T21:41:18.695Z","reviewedAt":"2026-10-15T21:41:18.695Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d04bb12f5ac7eb0ced51f43024c0a2c575f0d09b884de34c37a2a8c878fbb39e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/google-ventures"},{"id":"b7ec6fab-4be0-41b6-96c9-9ceb75fd50b7","kind":"institutions","code":"UB-I2076","name":"Logos Capital","nameBasis":"original-brand","summary":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","description":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","country":null,"category":null,"originalName":"Logos Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.060Z","englishUpdatedAt":"2026-10-15T20:40:58.196Z","reviewedAt":"2026-10-15T20:40:58.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a0ed63ab290a2e3701938597d81337fc2cc3ae0dc591169e160b435a279ba6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/logos-capital"},{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":null,"category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.617Z","englishUpdatedAt":"2026-10-15T21:44:15.515Z","reviewedAt":"2026-10-15T21:44:15.515Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dd32345516d11666ed6d26c7709c5384c09df6df2a3abb241dd8ddbe317f77e8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/takeda-pharmaceutical-co"}],"path":"/companies/beacon-biosignals","structured":{"city":"Boston","country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Beacon Biosignals is a company headquartered in Boston, United States, founded in 2019.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/beacon-biosignals"}